title: Is transjugular intrahepatic portosystemic shunt really deleterious for liver transplantation issue? A monocentric study on 86 liver transplanted patients.
authors.affiliation: Medico-Surgical Liver Unit, Conception Hospital, Marseille, France.
authors.forename: P
authors.initials: P
authors.lastname: Castellani
authors.forename: P
authors.initials: P
authors.lastname: Campan
authors.forename: D
authors.initials: D
authors.lastname: Bernardini
authors.forename: G
authors.initials: G
authors.lastname: Moulin
authors.forename: J M
authors.initials: JM
authors.lastname: Bartoli
authors.forename: Y P
authors.initials: YP
authors.lastname: Le Treut
authors.forename: A P
authors.initials: AP
authors.lastname: Gauthier
authors.forename: D
authors.initials: D
authors.lastname: Botta-Fridlund
mesh_terms: D016063:Blood Loss, Surgical / Q000517:prevention & control; D006801:Humans; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000502:physiology*; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects*; D012189:Retrospective Studies; D016896:Treatment Outcome